LineaRx, Inc., based in Stony Brook, NY, is a pioneering biotechnology company focused on revolutionizing therapeutic DNA manufacturing. As a subsidiary of Applied DNA Sciences, Inc., LineaRx is dedicated to producing high-quality DNA for nucleic acid-based therapies using their innovative LinearDNA platform, which offers faster production, higher purity, and enhanced scalability compared to traditional methods.
With a deep expertise in enzymatic DNA manufacturing and polymerase chain reaction (PCR), LineaRx is at the forefront of accelerating innovation in nucleic acid-based therapies, including mRNA, Cellular and Gene Therapy, and DNA Vaccines. Their cutting-edge approach, named LinearDNA or linDNA, aims to meet the growing demand for next-generation DNA supply to drive advancements in healthcare from research and development through to commercial manufacturing.
Generated from the website